PPARA and heart failure: Although glitazars improved metabolic parameters, they induced cardiac failure, which is probably due to glucolipotoxicity through the combined increase of PPARγ-driven insulin sensitization and glucose uptake in the setting of higher PPARα-induced activation of fatty acid uptake and oxidation.